Red cell distribution width and risk of peripheral artery disease: Analysis of National Health and Nutrition Examination Survey 1999-2004

Vascular Medicine (United Kingdom)

Volumn 17, Issue 3, 2012, Pages 155-163

  Zalawadiya, Sandip K ^a   Veeranna, Vikas ^a   Panaich, Sidakpal S ^a   Afonso, Luis ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

peripheral artery disease; RDW

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; HEMOGLOBIN; INSULIN; ORAL ANTIDIABETIC AGENT;

ACCURACY; ADULT; AGED; ANKLE BRACHIAL INDEX; ANTIHYPERTENSIVE THERAPY; BODY MASS; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; CYANOCOBALAMIN DEFICIENCY; DIABETES MELLITUS; ERYTHROCYTE PARAMETERS; FEMALE; FOLIC ACID DEFICIENCY; GLOMERULUS FILTRATION RATE; HIGH RISK POPULATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN TREATMENT; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RED CELL DISTRIBUTION WIDTH; REVIEW; SCREENING; SMOKING;

ADULT; AGED; ANKLE BRACHIAL INDEX; AREA UNDER CURVE; CROSS-SECTIONAL STUDIES; DATA COLLECTION; ERYTHROCYTE INDICES; ERYTHROCYTES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE; UNITED STATES;

EID: 84861837069     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X12442443     Document Type: Review

References (31)

1. Tefferi A, Hanson CA, Inwards DJ. How to interpret and pursue an abnormal complete blood cell count in adults. Mayo Clin Proc. 2005 ; 80: 923-936 (Pubitemid 40911466)
2. Felker GM, Allen LA, Pocock SJ, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007 ; 50: 40-47 (Pubitemid 46963527)
3. Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med. 2009 ; 169: 515-523
4. Patel KV, Semba RD, Ferrucci L, et al. Red cell distribution width and mortality in older adults: a meta-analysis. J Gerontol A Biol Sci Med Sci. 2010 ; 65: 258-265
5. Perlstein TS, Weuve J, Pfeffer MA, Beckman JA. Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med. 2009 ; 169: 588-594
6. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008 ; 117: 163-168
7. Zalawadiya SK, Zmily H, Farah J, Daifallah S, Ali O, Ghali JK. Red cell distribution width and mortality in predominantly African-American population with decompensated heart failure. J Card Fail. 2011 ; 17: 292-298
8. Zalawadiya SK, Veeranna V, Niraj A, Pradhan J, Afonso L. Red cell distribution width and risk of coronary heart disease events. Am J Cardiol. 2010 ; 106: 988-993
9. Forhecz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohaszka Z, Janoskuti L. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J. 2009 ; 158: 659-666
10. Allen LA, Felker GM, Mehra MR, et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail. 2010 ; 16: 230-238
11. Afonso L, Zalawadiya SK, Veeranna V, Panaich SS, Niraj A, Jacob S. Relationship between red cell distribution width and microalbuminuria: a population-based study of multiethnic representative US adults. Nephron Clin Pract. 2011 ; 119: c277 - c282
12. Loffredo L, Marcoccia A, Pignatelli P, et al. Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease. Eur Heart J. 2007 ; 28: 608-612 (Pubitemid 47355519)
13. Beckman JA, Preis O, Ridker PM, Gerhard-Herman M. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death). Am J Cardiol. 2005 ; 96: 1374-1378 (Pubitemid 41566616)
14. Wildman RP, Muntner P, Chen J, Sutton-Tyrrell K, He J. Relation of inflammation to peripheral arterial disease in the national health and nutrition examination survey, 1999-2002. Am J Cardiol. 2005 ; 96: 1579-1583 (Pubitemid 41690183)
15. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998 ; 97: 425-428 (Pubitemid 28090212)
16. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation. 2005 ; 112: 976-983 (Pubitemid 41170265)
17. Krzyzanowska K, Mittermayer F, Krugluger W, et al. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes. Atherosclerosis. 2006 ; 189: 236-240 (Pubitemid 44441289)
18. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006 ; 113: e463-654
19. NCHS Research Ethics Review Board (ERB) approval. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS). Available at: www.cdc.gov/nchs/nhanes/irba98.htm (accessed 15 March 2010).
20. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire (or Examination Protocol, or Laboratory Protocol). Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention, 1999-2004 [www.cdc.gov/nchs/nhanes/nhanes-questionnaires.htm].
21. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006 ; 145: 247-254 (Pubitemid 46768608)
22. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA. 1997 ; 277: 973-976 (Pubitemid 27142364)
23. Crawford JH, Chacko BK, Kevil CG, Patel RP. The red blood cell and vascular function in health and disease. Antioxid Redox Signal. 2004 ; 6: 992-999 (Pubitemid 39434935)
24. Comporti M, Signorini C, Buonocore G, Ciccoli L. Iron release, oxidative stress and erythrocyte ageing. Free Radic Biol Med. 2002 ; 32: 568-576 (Pubitemid 34241489)
25. Yelinova V, Glazachev Y, Khramtsov V, Kudryashova L, Rykova V, Salganik R. Studies of human and rat blood under oxidative stress: changes in plasma thiol level, antioxidant enzyme activity, protein carbonyl content, and fluidity of erythrocyte membrane. Biochem Biophys Res Commun. 1996 ; 221: 300-303 (Pubitemid 26136466)
26. Minetti M, Agati L, Malorni W. The microenvironment can shift erythrocytes from a friendly to a harmful behavior: pathogenetic implications for vascular diseases. Cardiovasc Res. 2007 ; 75: 21-28 (Pubitemid 46873513)
27. Minetti M, Malorni W. Redox control of red blood cell biology: the red blood cell as a target and source of prooxidant species. Antioxid Redox Signal. 2006 ; 8: 1165-1169 (Pubitemid 44182415)
28. Berliner S, Rogowski O, Aharonov S, et al. Erythrocyte adhesiveness/aggregation: a novel biomarker for the detection of low-grade internal inflammation in individuals with atherothrombotic risk factors and proven vascular disease. Am Heart J. 2005 ; 149: 260-267 (Pubitemid 40348531)
29. Pande RL, Perlstein TS, Beckman JA, Creager MA. Association of insulin resistance and inflammation with peripheral arterial disease: the National Health and Nutrition Examination Survey, 1999 to 2004. Circulation. 2008 ; 118: 33-41
30. O'Hare AM, Glidden DV, Fox CS, Hsu CY. High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation. 2004 ; 109: 320-323 (Pubitemid 38133897)
31. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004 ; 110: 738-743 (Pubitemid 39056275)